Related Experiment Videos

Importance, morbidity, and mortality of pneumonia in the surgical intensive care unit

Barie1

  • 1Department of Surgery, New York-Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York, USA

Insights

Nosocomial pneumonia is a risk for surgical patients, with Staphylococcus aureus and Pseudomonas aeruginosa common. Acinetobacter is an emerging pathogen, complicating diagnosis and attributing outcomes in critically ill patients.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Surgical Infections

Background:

  • Surgical patients face a high risk of developing nosocomial pneumonia.
  • Accurate diagnosis of nosocomial pneumonia in this population is challenging.
  • Common pathogens include Staphylococcus aureus and Pseudomonas aeruginosa, with Acinetobacter emerging.

Purpose of the Study:

  • To highlight the diagnostic challenges of nosocomial pneumonia in surgical patients.
  • To identify common and emerging pathogens responsible for nosocomial pneumonia.
  • To discuss the difficulties in attributing morbidity and mortality to infection in critically ill surgical patients.

Main Methods:

  • Literature review of nosocomial pneumonia in surgical settings.
  • Analysis of common and emerging microbial pathogens.
  • Discussion of diagnostic and attribution challenges in critically ill patients.

Main Results:

  • Nosocomial pneumonia is a significant complication in surgical patients.
  • Staphylococcus aureus and Pseudomonas aeruginosa are prevalent pathogens.
  • Acinetobacter is an increasingly important pathogen in this demographic.

Conclusions:

  • Accurate diagnosis of nosocomial pneumonia in surgical patients remains difficult.
  • The emergence of pathogens like Acinetobacter requires updated diagnostic and treatment strategies.
  • Multisystem pathology in critically ill patients complicates the direct attribution of outcomes to infection.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: